Alexander McCampbell

5.4k total citations · 2 hit papers
21 papers, 2.7k citations indexed

About

Alexander McCampbell is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Alexander McCampbell has authored 21 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 6 papers in Physiology. Recurrent topics in Alexander McCampbell's work include Alzheimer's disease research and treatments (5 papers), Neurogenetic and Muscular Disorders Research (4 papers) and Genetic Neurodegenerative Diseases (4 papers). Alexander McCampbell is often cited by papers focused on Alzheimer's disease research and treatments (5 papers), Neurogenetic and Muscular Disorders Research (4 papers) and Genetic Neurodegenerative Diseases (4 papers). Alexander McCampbell collaborates with scholars based in United States, United Kingdom and Italy. Alexander McCampbell's co-authors include Joan S. Steffan, Kenneth H. Fischbeck, Leslie M. Thompson, Riki Kurokawa, J. Lawrence Marsh, Judit Pallos, László Bodai, David E. Housman, George R. Jackson and Barbara L. Apostol and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Alexander McCampbell

21 papers receiving 2.6k citations

Hit Papers

Histone deacetylase inhibitors arrest polyglutamine-depen... 2001 2026 2009 2017 2001 2017 250 500 750

Peers

Alexander McCampbell
Svetlana Vidensky United States
Hibiki Kawamata United States
Rachel M. Bailey United States
Leah Boyer United States
Alexander McCampbell
Citations per year, relative to Alexander McCampbell Alexander McCampbell (= 1×) peers Simonetta Sipione

Countries citing papers authored by Alexander McCampbell

Since Specialization
Citations

This map shows the geographic impact of Alexander McCampbell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander McCampbell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander McCampbell more than expected).

Fields of papers citing papers by Alexander McCampbell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander McCampbell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander McCampbell. The network helps show where Alexander McCampbell may publish in the future.

Co-authorship network of co-authors of Alexander McCampbell

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander McCampbell. A scholar is included among the top collaborators of Alexander McCampbell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander McCampbell. Alexander McCampbell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bora, Pranami, Silvia Parolo, Michael Monine, et al.. (2022). An age‐dependent mathematical model of neurofilament trafficking in healthy conditions. CPT Pharmacometrics & Systems Pharmacology. 11(4). 447–457. 9 indexed citations
2.
Marsh, Galina, Shanqin Xu, Kathryn Koszka, et al.. (2021). Use of CRISPR/Cas9-mediated disruption of CNS cell type genes to profile transduction of AAV by neonatal intracerebroventricular delivery in mice. Gene Therapy. 28(7-8). 456–468. 13 indexed citations
3.
Kankel, Mark W., Anindya Sen, Lei Lü, et al.. (2020). Amyotrophic Lateral Sclerosis Modifiers inDrosophilaReveal the Phospholipase D Pathway as a Potential Therapeutic Target. Genetics. 215(3). 747–766. 22 indexed citations
4.
Darras, Basil T., Thomas O. Crawford, Richard S. Finkel, et al.. (2019). Neurofilament as a potential biomarker for spinal muscular atrophy. Annals of Clinical and Translational Neurology. 6(5). 932–944. 152 indexed citations
5.
Ling, Karen, Michaela Jackson, Duah Alkam, et al.. (2018). Antisense-mediated reduction of EphA4 in the adult CNS does not improve the function of mice with amyotrophic lateral sclerosis. Neurobiology of Disease. 114. 174–183. 18 indexed citations
6.
Sweeney, Patrick, Hyunsun Park, Marc Baumann, et al.. (2017). Protein misfolding in neurodegenerative diseases: implications and strategies. Translational Neurodegeneration. 6(1). 6–6. 462 indexed citations breakdown →
7.
Periz, Goran, Jiayin Lu, Tao Zhang, et al.. (2015). Regulation of Protein Quality Control by UBE4B and LSD1 through p53-Mediated Transcription. PLoS Biology. 13(4). e1002114–e1002114. 36 indexed citations
8.
Staropoli, John F., Seung Chun, Norm Allaire, et al.. (2015). Rescue of gene-expression changes in an induced mouse model of spinal muscular atrophy by an antisense oligonucleotide that promotes inclusion of SMN2 exon 7. Genomics. 105(4). 220–228. 29 indexed citations
9.
Converso, Antonella, Mark E. Fraley, R. M. Garbaccio, et al.. (2014). Adenosine analogue inhibitors of S-adenosylhomocysteine hydrolase. Bioorganic & Medicinal Chemistry Letters. 24(12). 2737–2740. 12 indexed citations
10.
Savage, Mary J., Juliya Kalinina, Abigail Wolfe, et al.. (2014). A Sensitive Aβ Oligomer Assay Discriminates Alzheimer's and Aged Control Cerebrospinal Fluid. Journal of Neuroscience. 34(8). 2884–2897. 125 indexed citations
11.
Yang, Xiaoyu, Wei Xu, Sabrina A. Benchaar, et al.. (2013). Developability studies before initiation of process development. mAbs. 5(5). 787–794. 90 indexed citations
12.
Wolfe, Abigail, Alexander McCampbell, Katherine Tugusheva, et al.. (2012). P2‐043: A quantitative assay selective for amyloid oligomer species differentiates cerebrospinal fluid from Alzheimer's disease and age‐matched normal. Alzheimer s & Dementia. 8(4S_Part_8). 3 indexed citations
13.
Gotter, Anthony L., Vincent P. Santarelli, Scott M. Doran, et al.. (2011). TASK-3 as a potential antidepressant target. Brain Research. 1416. 69–79. 35 indexed citations
14.
McCampbell, Alexander, Michael W. Marlatt, Dawn Toolan, et al.. (2010). Induction of Alzheimer’s-like changes in brain of mice expressing mutant APP fed excess methionine. Journal of Neurochemistry. 116(1). 82–92. 19 indexed citations
15.
Savage, Mary J., Guoxin Wu, Alexander McCampbell, et al.. (2010). O3‐07‐03: A novel multivalent Abeta peptide vaccine with preclinical evidence of a central immune response that generates antisera recognizing a wide range of Abeta peptide species. Alzheimer s & Dementia. 6(4S_Part_5). 11 indexed citations
16.
Dionne, Annie, Denis Brunet, Alexander McCampbell, & Nicolas Dupré. (2005). Adrenomyeloneuropathy: Report of a New Mutation in a French Canadian Female. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 32(2). 261–263. 2 indexed citations
17.
Steffan, Joan S., László Bodai, Judit Pallos, et al.. (2001). Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature. 413(6857). 739–743. 964 indexed citations breakdown →
18.
McCampbell, Alexander, et al.. (2001). Histone deacetylase inhibitors reduce polyglutamine toxicity. Proceedings of the National Academy of Sciences. 98(26). 15179–15184. 193 indexed citations
19.
McCampbell, Alexander & Kenneth H. Fischbeck. (2001). Polyglutamine and CBP: Fatal attraction?. Nature Medicine. 7(5). 528–530. 69 indexed citations
20.
McCampbell, Alexander. (2000). CREB-binding protein sequestration by expanded polyglutamine. Human Molecular Genetics. 9(14). 2197–2202. 443 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026